Buscar resultados de ensayos clínicos
Neisseriaceae Infections - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Hormonal Contraception and Risk of Chlamydia and Gonorrhea Condición:
Fecha: 2004-09-16 Intervenciones:
|
Recruiting |
Nombre del estudio: South Australian Meningococcal B Vaccine Herd Immunity Study Condición: Meningococcal Disease Fecha: 2017-03-17 Intervenciones: Biological: Licensed 4CMenB vaccine Two doses (0.5 mL each) of Bexsero ® vaccine at least 1 month t |
Recruiting |
Nombre del estudio: Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination Condición: Infections, Meningococcal Fecha: 2016-12-06 Intervenciones: Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo) |
Recruiting |
Nombre del estudio: Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents Condición: Infections, Meningococcal Fecha: 2016-10-25 Intervenciones:
|
Recruiting |
Nombre del estudio: PRIME Follow up - Quadri Meningo Vacinees Condición: Meningococcal Disease Fecha: 2016-06-15 Intervenciones: Other: venepuncture only single venepuncture |
Active, not recruiting |
Nombre del estudio: Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization Condición: Meningococcal Infections Fecha: 2016-03-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine Condición: Meningococcal Disease Fecha: 2015-12-21 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) Condición: Meningococcal Infections Fecha: 2015-09-30 Intervenciones: Biological: Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals) All subjects will receive three doses of a T |
Completed |
Nombre del estudio: A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years Condición: MENINGOCOCCAL INFECTION Fecha: 2015-08-20 Intervenciones:
|
Completed |
Nombre del estudio: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) Condición: Meningococcal Disease Fecha: 2015-05-04 Intervenciones: Biological: MenABCWY+OMV vaccine Intramuscular injection of a single dose at Day 1 to subjects in the Me |